High Note Wealth’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,568
Closed -$11.6K 934
2025
Q1
$11.6K Hold
2,568
﹤0.01% 277
2024
Q4
$18.2K Buy
+2,568
New +$20.5K ﹤0.01% 244

Other funds holding HCAT

High Note Wealth's HCAT Position: Q2 2025 in Review

High Note Wealth sold out of Health Catalyst (HCAT) in Q2 2025, closing a stake of 2,568 shares — an estimated $11.6K sold.

High Note Wealth first reported a position in HCAT in Q4 2024 and held it in 2 quarters. The position peaked at $18.2K in Q4 2024. 145 funds tracked by Wall St. Rank hold HCAT as of Q2 2025.

  • High Note Wealth reported no remaining Health Catalyst position as of Q2 2025 after selling out during the quarter.
  • High Note Wealth sold 2,568 Health Catalyst shares in Q2 2025, an estimated $11.6K.
  • High Note Wealth first reported a position in Health Catalyst in Q4 2024 and held it in 2 quarters.
  • High Note Wealth's Health Catalyst position peaked at $18.2K in Q4 2024.
  • 145 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2025.

Based on High Note Wealth's 13F filing for Q2 2025, filed 23 Jul 2025.